Back to search

Article

Metabolomics-Enhanced Liquid Biopsy Identifies Early Heptocellular Injury in Females with MetALD

2026-04-14

Abstract excerpt

<h4>Background: </h4> Steatotic liver disease (SLD) is characterised by profound metabolic reprogramming, yet no single biomarker reliably distinguishes disease entities, stages or sex-specific risk profiles. By integrating serum metabolomic signatures as a liquid biopsy with tumour-associated CSC marker profiles in a sex-stratified analytical framework, we aimed to identify biologically meaningful differences and impr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
af899ab1-b484-505f-b5b1-11907f68b94c
DOI
10.20944/preprints202604.0876.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Metabolomics-Enhanced Liquid Biopsy Identifies Early Heptocellular Injury in Females with MetALDDOI 10.20944/preprints202604.0876.v1
Metabolomics and Lipidomics Screening Reveal Reprogrammed Signaling Pathways toward Cancer Development in Non-Alcoholic SteatohepatitisSemantic proximity
Elevated serum apolipoprotein B and lipoprotein remodelling distinguish adults with HLH from HLH mimics and controlsSemantic proximity
A paired liver biopsy and plasma proteomics study reveals circulating biomarkers for alcohol-related liver diseaseSemantic proximity
Primary Liver Cancers: Connecting the Dots of Cellular Studies and Epidemiology with MetabolomicsSemantic proximity
An Integrated Multi-omic Analysis Reveals Novel Gene-Metabolite Relationships in Human Steatohepatitic Hepatocellular CarcinomaSemantic proximity
Association of the Liver and Plasma Lipidomes with the Histological Stage of Alcohol-Related Liver DiseaseSemantic proximity
NMR-based metabolomics in human disease diagnosis: applications, limitations, and recommendationsSemantic proximity
Translating Patient‑Specific Liver Organoid Multi‑Omics into Precision Diagnostics and Risk Stratification for Herb‑Induced Liver Injury: A Systematic ReviewSemantic proximity
Identification of serum metabolite biomarkers and metabolic reprogramming mechanisms to predict recurrence in cholangiocarcinomaSemantic proximity
Phosphatidylethanol levels distinguish steatotic liver disease subgroups and are associated with risk of major liver outcomesSemantic proximity
Biomarkers of NAFLD progression: a lipidomics approach to an epidemic.Semantic proximity
Alcohol-driven phenotypic transition in MASLD and risk of liver-related events.Semantic proximity
Select a neighboring publication to make it the new centre.